Literature DB >> 23449799

Human cytomegalovirus pp71 stimulates major histocompatibility complex class i presentation of IE1-derived peptides at immediate early times of infection.

Julia Hesse1, Sabine Reyda, Stefan Tenzer, Katrin Besold, Nina Reuter, Steffi Krauter, Nicole Büscher, Thomas Stamminger, Bodo Plachter.   

Abstract

Suppression of major histocompatibility complex (MHC) class I-mediated presentation of human cytomegalovirus (HCMV) peptides is an important mechanism to avoid CD8 T lymphocyte recognition and killing of infected cells. Of particular interest is how MHC class I presentation of essential regulatory immediate early (IE) proteins of HCMV can be effectively compromised at times when known viral immunoevasins are not abundantly expressed. The tegument protein pp71 had been suggested to be involved in MHC class I downregulation. Intriguingly, this polypeptide is also critically engaged in the initial derepression of the major IE gene locus, leading to enhanced expression of IE proteins IE1-pp72 and IE2-pp86. Using a set of viral mutants, we addressed the role of pp71 in MHC class I presentation of IE1-pp72-derived peptides. We show that the amount of "incoming" pp71 positively correlates with IE1-pp72 protein levels and with the presentation of IE1-derived peptides. This indicates that the amount of the IE1 protein, induced by pp71, rather than a putative immunoevasive function of the tegument protein, determines MHC class I antigen presentation of IE1-derived peptides. This process proved to be independent of the presence of pp65, which had been reported to interfere with IE1 presentation. It may thus be beneficial for the success of HCMV replication to limit the level of pp71 delivered from infecting particles in order to avoid critical levels of MHC class I presentation of IE protein-derived peptides.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23449799      PMCID: PMC3624312          DOI: 10.1128/JVI.03484-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  Quantitative proteomic analysis by accurate mass retention time pairs.

Authors:  Jeffrey C Silva; Richard Denny; Craig A Dorschel; Marc Gorenstein; Ignatius J Kass; Guo-Zhong Li; Therese McKenna; Michael J Nold; Keith Richardson; Phillip Young; Scott Geromanos
Journal:  Anal Chem       Date:  2005-04-01       Impact factor: 6.986

2.  Preemptive CD8 T-cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genomes, and reduces the risk of virus recurrence.

Authors:  H P Steffens; S Kurz; R Holtappels; M J Reddehase
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

3.  Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product.

Authors:  M J Gilbert; S R Riddell; B Plachter; P D Greenberg
Journal:  Nature       Date:  1996-10-24       Impact factor: 49.962

4.  Development of a candidate HLA A*0201 restricted peptide-based vaccine against human cytomegalovirus infection.

Authors:  D J Diamond; J York; J Y Sun; C L Wright; S J Forman
Journal:  Blood       Date:  1997-09-01       Impact factor: 22.113

5.  Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains.

Authors:  T R Jones; E J Wiertz; L Sun; K N Fish; J A Nelson; H L Ploegh
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

6.  The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.

Authors:  M R Wills; A J Carmichael; K Mynard; X Jin; M P Weekes; B Plachter; J G Sissons
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

7.  Two distinct upstream regulatory domains containing multicopy cellular transcription factor binding sites provide basal repression and inducible enhancer characteristics to the immediate-early IES (US3) promoter from human cytomegalovirus.

Authors:  Y J Chan; W P Tseng; G S Hayward
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

8.  Target structures of the CD8(+)-T-cell response to human cytomegalovirus: the 72-kilodalton major immediate-early protein revisited.

Authors:  F Kern; I P Surel; N Faulhaber; C Frömmel; J Schneider-Mergener; C Schönemann; P Reinke; H D Volk
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

9.  The dominant phosphoprotein pp65 (UL83) of human cytomegalovirus is dispensable for growth in cell culture.

Authors:  S Schmolke; H F Kern; P Drescher; G Jahn; B Plachter
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

10.  Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor.

Authors:  E A Walter; P D Greenberg; M J Gilbert; R J Finch; K S Watanabe; E D Thomas; S R Riddell
Journal:  N Engl J Med       Date:  1995-10-19       Impact factor: 91.245

View more
  7 in total

1.  The tegument protein pp65 of human cytomegalovirus acts as an optional scaffold protein that optimizes protein uploading into viral particles.

Authors:  Sabine Reyda; Stefan Tenzer; Pedro Navarro; Wolfgang Gebauer; Michael Saur; Steffi Krauter; Nicole Büscher; Bodo Plachter
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

2.  The Abundant Tegument Protein pUL25 of Human Cytomegalovirus Prevents Proteasomal Degradation of pUL26 and Supports Its Suppression of ISGylation.

Authors:  Christine Zimmermann; Nicole Büscher; Steffi Krauter; Nadine Krämer; Uwe Wolfrum; Elisabeth Sehn; Stefan Tenzer; Bodo Plachter
Journal:  J Virol       Date:  2018-11-27       Impact factor: 5.103

3.  A Micropolymorphism Altering the Residue Triad 97/114/156 Determines the Relative Levels of Tapasin Independence and Distinct Peptide Profiles for HLA-A(*)24 Allotypes.

Authors:  Soumya Badrinath; Heike Kunze-Schumacher; Rainer Blasczyk; Trevor Huyton; Christina Bade-Doeding
Journal:  J Immunol Res       Date:  2014-12-04       Impact factor: 4.818

4.  Proteomic analyses of human cytomegalovirus strain AD169 derivatives reveal highly conserved patterns of viral and cellular proteins in infected fibroblasts.

Authors:  Sabine Reyda; Nicole Büscher; Stefan Tenzer; Bodo Plachter
Journal:  Viruses       Date:  2014-01-07       Impact factor: 5.048

Review 5.  Classical and non-classical MHC I molecule manipulation by human cytomegalovirus: so many targets—but how many arrows in the quiver?

Authors:  Anne Halenius; Carolin Gerke; Hartmut Hengel
Journal:  Cell Mol Immunol       Date:  2014-11-24       Impact factor: 11.530

Review 6.  Expanding the Known Functional Repertoire of the Human Cytomegalovirus pp71 Protein.

Authors:  Robert F Kalejta; Emily R Albright
Journal:  Front Cell Infect Microbiol       Date:  2020-03-12       Impact factor: 5.293

7.  HCMV Infection in a Mesenchymal Stem Cell Niche: Differential Impact on the Development of NK Cells versus ILC3.

Authors:  Ricarda Ising; Sandra Weinhold; Sabrina Bianca Bennstein; Albert Zimmermann; Özer Degistirici; Gesine Kögler; Roland Meisel; Hartmut Hengel; Jörg Timm; Markus Uhrberg
Journal:  J Clin Med       Date:  2019-12-19       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.